Top Stories
-
Columbia researchers have shined new light on how the “dark” part of the genome allows cancer cells to be detected by the immune system, which could lead to better immunotherapies.
-
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Topic
-
In the past decade, physicians have recommended that women undergoing some surgeries have their fallopian tubes removed at the same time to prevent ovarian cancer.
Topic
-
Columbia expert Dr. Fatemeh Momen-Heravi shares facts about HPV-related cancer risk factors and prevention.
Topic
Latest News
- November 5, 2020
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
Topic
- October 29, 2020
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
Topic
- October 22, 2020
Columbia's Eileen Connolly explains how radiation treatment for breast cancer has vastly improved in recent years due to advancements in technology and an increased understanding of the disease.
Topic
- October 15, 2020
Breast cancer survival has improved by about 40% since the 1980s. Columbia oncologist Katherine Crew discusses how new genetic tests, treatments, and screening methods should further improve survival.
Topic
- September 29, 2020
Columbia is one of the few places in the world where scientists can research an emerging radiotherapy technique called FLASH, which could drastically shorten radiation treatment for cancer patients.
Topic
- September 25, 2020
Velocity, Columbia’s annual fundraiser for cancer research, has changed this year, with participants cycling, running, and even sailing to support cancer research and care.
Topic
- August 26, 2020
The Herbert Irving Comprehensive Cancer Center has been redesignated as a Comprehensive Cancer Center by the NCI, the federal government’s principal agency for cancer research, care, and training.
Topic
- August 20, 2020
A study of cancer patients with COVID-19 finds mortality is significantly higher than in the general population and Black patients are half as likely to receive the antiviral remdesivir.
- July 31, 2020
A breast cancer patient explains how her treatment team unflinchingly continued her care during the COVID-19 pandemic.
Topic
- June 10, 2020
Compared to yearly screening, more frequent mammograms for women treated for early-stage breast cancer did not confer additional benefit, a study from Columbia University oncologists has found.
Topic
